| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/07/2002 | WO2001070130A3 Compositions derived from modiolus modiolus and methods for making and using same |
| 02/07/2002 | WO2001050866A3 Method and device for sanitation using bacteriophages |
| 02/07/2002 | WO2001043770A3 Method for enhancing immune responses in mammals |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | WO2001034653A3 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 02/07/2002 | WO2001034206A3 Nucleic acid-containing complex |
| 02/07/2002 | WO2001032841A3 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 02/07/2002 | US20020016335 Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy |
| 02/07/2002 | US20020016305 Yeast genes that affect viral replication |
| 02/07/2002 | US20020016299 Containing glycerolipid and/or glyceroglycolipid as effective component(s). |
| 02/07/2002 | US20020016244 Method for separating cells, especially platelets, and bag assembly therefor |
| 02/07/2002 | US20020016002 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 02/07/2002 | US20020016000 Methods of isolating hepatic progenitors |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015744 Dietetic supplements; cognition activators |
| 02/07/2002 | US20020015739 Compounds inhibiting COX-2 and iNOS promoter activities |
| 02/07/2002 | US20020015738 Peptides; animal extracts |
| 02/07/2002 | US20020015725 Wound healing agents |
| 02/07/2002 | US20020015709 Administration of leptin |
| 02/07/2002 | US20020015696 Modulation of expression of nucleotide sequences encoding transcription factors; antidiabetic agents |
| 02/07/2002 | US20020015695 Herpesviral vectors for gene delivery |
| 02/07/2002 | US20020015694 Hematopoietic differentiation of human embryonic stem cells |
| 02/07/2002 | DE10035433A1 Schonende Hochanreicherung von fetalen Zellen aus pripherem Blut und Verwendung derselben Gentle high enrichment of fetal cells from blood pripherem and using the same |
| 02/07/2002 | CA2455170A1 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | CA2418072A1 Insulin producing cell-line obtained by electrofusion |
| 02/07/2002 | CA2417688A1 Tissue implant for cartilage repair |
| 02/07/2002 | CA2417566A1 Purifying crude pufa oils |
| 02/07/2002 | CA2417364A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | CA2417356A1 Directed differentiation of embryonic cells |
| 02/07/2002 | CA2417345A1 Method of cloning porcine animals |
| 02/07/2002 | CA2416893A1 Modified cea and uses thereof |
| 02/07/2002 | CA2416877A1 Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 02/07/2002 | CA2416788A1 Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416700A1 Cell implantation therapy for neurological diseases or disorders |
| 02/07/2002 | CA2415647A1 Neospora caninum isolate |
| 02/07/2002 | CA2406311A1 Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
| 02/06/2002 | EP1178116A1 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 02/06/2002 | EP1178115A2 Phosphodiesterase |
| 02/06/2002 | EP1178103A1 Purifying crude pufa oils |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1177794A2 Composition, containing lactobacillus bulgaricus and streptococcus thermophilus, for the treatment of gastrointestinal disorders, hyperlipidemia, autoimmune diseases, and obesity |
| 02/06/2002 | EP1177298A1 Autotaxin variants and uses to treat diseases of metabolism |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177290A2 Recombinant laminin 5 |
| 02/06/2002 | EP1177157A1 A vital matter and a producing method |
| 02/06/2002 | EP1176986A1 Differentiation of monocytes into functional dendritic cells |
| 02/06/2002 | EP1176970A2 Xenotransplant for cns therapy |
| 02/06/2002 | EP1176964A1 Compositions and uses of et743 for treating cancer |
| 02/06/2002 | EP1176938A1 Biomimetic water solutions and compositions, their use as and in health and beauty care products and the methods to prepare them |
| 02/06/2002 | EP1176870A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 02/06/2002 | EP1030677B1 Synergetic oral composition combining salmon dna with hydroxyproline |
| 02/06/2002 | EP0832267B1 Adenovirus vectors for gene therapy |
| 02/06/2002 | EP0712936B1 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 02/06/2002 | EP0670896B1 Cloning and expression of biologically active alpha-galactosidase a |
| 02/06/2002 | CN1334878A Polynucleotide comprising ubiquitous chromatin opening element (UCDE) |
| 02/06/2002 | CN1334121A Medicinal composition for restoring cardiac collaterals and its application |
| 02/06/2002 | CN1334119A Litholysizing bear gall powder |
| 02/06/2002 | CN1334115A Medicinal liquor for treating sexual disfunction and its preparing process |
| 02/06/2002 | CN1334114A Chinese medicine for treating mastoplasia |
| 02/06/2002 | CN1334112A Chinese medicine for treaitng coronary heart disease |
| 02/06/2002 | CN1334104A Hypolipemic pill |
| 02/06/2002 | CN1334101A Defervescent and its preparing process |
| 02/06/2002 | CN1334099A Process for prepairng medicine to treat facial paralysis |
| 02/06/2002 | CN1334091A Earthworm-compound enzyme for feed and its preparing process |
| 02/06/2002 | CN1334090A Earthworm-amino acid zinc for feed and its preparing process |
| 02/06/2002 | CN1334089A Process for preparing earthworm medicine to treat beriberi |
| 02/06/2002 | CN1334088A Process for preparing multi-vitamine bone peptide extract |
| 02/06/2002 | CN1334087A Injection for treating piles and its preparing process |
| 02/05/2002 | US6344550 A dna molecule; diagnosing, monitoring and therapy of breast cancer |
| 02/05/2002 | US6344437 Medicine drink food and feed having an action of strengthening bone |
| 02/05/2002 | US6344220 Cayenne, turmeric, ginger, yucca, devil's claw, nettle leaf, black cohosh, alfalfa, celery seeds, glucosamine hydrochloride and mucopolysaccharides; antiartthritic, antiinflamatory agents, analgesics, immunosupressants |
| 02/05/2002 | US6344217 Washing egg shells with purified water, stirring, autoclaving, drying crushing to desired grain size; used for bone disorders and oral diseases |
| 02/05/2002 | US6344195 Administering reovirus to a ras-mediated neoplasm |
| 02/05/2002 | US6344194 Dissolving a virus in an aqueous solution containing 6-12 g/l of a monovalent cation salt (such as nacl or kcl), or 50-100 g/l of a hexose and atomizing |
| 02/05/2002 | CA2098113C Substances of polypeptide nature useful in human therapy |
| 02/05/2002 | CA2058635C Treatment of thrombotic events |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 01/31/2002 | WO2002008751A2 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 01/31/2002 | WO2002008435A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | WO2002008389A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 01/31/2002 | WO2002008388A2 Stem cell-like cells |
| 01/31/2002 | WO2002008387A1 Heart muscle-like cell sheet, three-dimensional construct, heart muscle-like tissue and process for producing the same |
| 01/31/2002 | WO2002008263A2 Modified virus having an altered tropism |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002007777A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |
| 01/31/2002 | WO2002007774A2 Methods for therapy of neurodegenerative disease of the brain |
| 01/31/2002 | WO2002007759A2 Clostridial toxin derivatives and methods for treating pain |
| 01/31/2002 | WO2002007752A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
| 01/31/2002 | WO2002007748A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 01/31/2002 | WO2002007742A2 Bacteriophage having multiple host range |
| 01/31/2002 | WO2002007741A1 Probiotic recolonisation therapy |
| 01/31/2002 | WO2002007739A2 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma |
| 01/31/2002 | WO2002007738A1 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 01/31/2002 | WO2002007679A2 Adult human dental pulp stem cells in vitro and in vivo |
| 01/31/2002 | WO2002007678A2 Mu-conopeptides |
| 01/31/2002 | WO2001083562A3 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/31/2002 | WO2001082773A3 Structures useful for bone engineering and methods |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |